Get Ready for CPHI: Off-Patent Semaglutide and Sustainability in a Shifting World
October 27, 2025
It’s showtime in Frankfurt – with around 62,000 attendees expected.
4 min read
False
      October 27, 2025
It’s showtime in Frankfurt – with around 62,000 attendees expected.
4 min read
October 15, 2025
With remarkable successes come inevitable hurdles. Find out what experts had to say about GLP-1 drug development during an AAPS workshop.
8 min read
By Charles Johnson
March 2, 2023
Pipelines are changing, and chemical complexity is on the rise. What can pharma manufacturers do about it?
4 min read
By Rob Coker
February 17, 2023
Ulrike Gnad-Vogt, Senior Vice President Area Head Oncology at CureVac, talks us through the company’s efforts to target seasonal influenza through mRNA-based vaccines – and what its platform means for the future of cancer treatment
3 min read
False
False
False